• Gary R. Robertson
Part of the Contemporary Endocrinology book series (COE, volume 2)


The past few years has been a time of rapid growth in our knowledge of vasopressin and neurohypophyseal function. In 1977, the major advances of the prior decade were represented by less than 150 papers.’ In the last 5 years, more than 250 papers exploring new or controversial aspects of vasopressin function have appeared. While this new growth occurred in many areas, it was particularly pronounced in those pertaining to basic anatomy, biochemistry, physiology, and pharmacology of the system. Some advances also were made in pathophysiology, diagnosis, and treatment, but much of the new information in these areas served to confirm and consolidate existing concepts. In the following sections, these new developments will be reviewed, giving particular attention to those that seem the most important, well developed, or controversial. Wherever it seems particularly important or helpful to understanding, pertinent historical material will also be reviewed. For more complete background material, the reader is referred to the initial chapter in the series.1


Diabetes Insipidus Plasma Osmolality Arginine Vasopressin Nephrogenic Diabetes Insipidus Vasopressin Release 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Robertson, G. L., 1978, Vasopressin and water metabolism, in: The Year in Endocrinology 1977 ( S. H. Ingbar, ed.), pp. 205–231, Plenum Medical, New York.CrossRefGoogle Scholar
  2. 2.
    Zimmerman, E. A., 1981, The organization of oxytocin and vasopressin pathways, in Neurosecretion and Brain Peptides U. B. Martin, S. Reichlin, and K. L. Bick, eds.), pp. 63–75, Raven Press, New York.Google Scholar
  3. 3.
    Sofroniew, M. V., Weindl, A., Schrell, U., and Wetzstein, R., 1981, Immunohistochemistry of vasopressin, oxytocin and neurophysin in the hypothalamus and extrahypothalamic regions of the human and primate brain, Acta Histochem. Suppl. 24: 79–95.PubMedGoogle Scholar
  4. 4.
    Dierickx, K., and Vandesande, F., 1977, Immunocytochemical localization of the vasopressinergic and the oxytocinergic neurons in the human hypothalamus, Cell Tissue Res. 184: 15–27.PubMedCrossRefGoogle Scholar
  5. 5.
    Sofroniew, M. V., and Weindl, A., 1978, Projections from the parvocellular vasopressin-and neurophysin-containing neurons of the suprachiasmatic nucleus, Am. J. Anat. 153: 391–430.PubMedCrossRefGoogle Scholar
  6. 6.
    Swanson, L. W., 1977, Immunohistochemical evidence for a neurophysincontaining automatic pathway arising in the paraventricular nucleus of the hypothalamus, Brain Res. 128: 346–353.PubMedCrossRefGoogle Scholar
  7. 7.
    Nilaver, G., Zimmerman, E. A., Wilkins, J., Michaels, J., Hoffman, D., and Silverman, A.-J., 1980, Magnocellular hypothalamic projections to the lower brain stem and spinal cord of the rat: Immunocytochemical evidence for predominance of the oxytocin—neurophysin system compared to the vasopressin—neurophysin system, Neuroendocrinology 30: 150–158.PubMedCrossRefGoogle Scholar
  8. 8.
    Luerssen, T. G., and Robertson, G. L., 1980, Cerebrospinal fluid vasopressin and vasotocin in health and disease, in: Neurobiology of Cerebrospinal Fluid, Vol. 1 U. H. Wood, ed.), pp. 613–623, Plenum Press, New York.CrossRefGoogle Scholar
  9. 9.
    Glick, S. M., and Brownstein, M. J., 1980, Vasopressin content of rat brain, Life Sci. 27: 1103–1110.PubMedCrossRefGoogle Scholar
  10. 10.
    Summy-Long, J. V., Keil, L. C., and Severs, W. B., 1978, Identification of vasopressin in the subfornical organ region: Effects of dehydration, Brain Res. 140: 241–250.PubMedCrossRefGoogle Scholar
  11. 11.
    Sachs, H., Fawcett, P., Takabatake, Y., and Portanova, R., 1969, Biosynthesis and release of vasopressin and neurophysin, Recent Prog. Horm. Res. 25: 447–491.PubMedGoogle Scholar
  12. 12.
    Russell, J. T., Brownstein, M. J., and Gainer, H., 1980, Biosynthesis of vasopressin, oxytocin, and neurophysins: Isolation and characterization of two common precursors (propressophysin and prooxyphysin), Endocrinology 107: 1880–1891.PubMedCrossRefGoogle Scholar
  13. 13.
    Brownstein, M. J., Russell, J. T., and Gainer, H., 1980, Synthesis, transport, and release of posterior pituitary hormones, Science 207: 373–378.PubMedCrossRefGoogle Scholar
  14. 14.
    Land, H., Schütz, G., Schmale, H., and Richter, D., 1982, Nucleotide sequence of cloned cDNA encoding bovine arginine vasopressin-neurophysin II precursor, Nature (London) 295: 299–303.CrossRefGoogle Scholar
  15. 15.
    Valtin, H., Sokol, H. W., and Sunde, D., 1975, Genetic approaches to the study of the regulation and actions of vasopressin, Recent Prog. Horm. Res. 31: 447–486.PubMedGoogle Scholar
  16. 16.
    Oiso, Y., Gaskill, M. B., Stamoutsos, B., Lindheimer, M., and Robertson, G. L., 1981, Vasopressin immunoactivity in Brattleboro rats with hereditary hypothalamic diabetes insipidus, Clin. Res. 29: 708A.Google Scholar
  17. 17.
    Edwards, B. R., Gellai, M., and Valtin, H., 1980, Concentration of urine in the absence of ADH with minimal or no decrease in GFR, Am. J. Physiol. 239: F84 — F91.PubMedGoogle Scholar
  18. 18.
    Weitzman, R. E., and Fisher, D. A., 1977, Log linear relationship between plasma arginine vasopressin and plasma osmolality, Am. J. Physiol. 233: E37 — E40.PubMedGoogle Scholar
  19. 19.
    Moses, A. M., 1978, Is there an osmotic threshold for vasopressin release?, Am. J. Physiol. 234: E339 — E340.PubMedGoogle Scholar
  20. 20.
    Rodbard, D., and Munson, P. J., 1978, Editorial comment, Am. J. Physiol. 234: E340 — E342.PubMedGoogle Scholar
  21. 21.
    Hammer, M., Ladegoged, J., and Olgaard, K., 1979, Relationship between plasma osmolality and plasma vasopressin in human subjects, Am. J. Physiol. 238: E313 — E317.Google Scholar
  22. 22.
    Weitzman, R. E., Fisher, D. A., DiStefano, J. H., III, and Bennett, C. M., 1977, Episodic secretion of arginine vasopressin, Am. J. Physiol. 233: E32 — E36.PubMedGoogle Scholar
  23. 23.
    Robertson, G. L., Athar, S., and Shelton, R. L., 1977, Osmotic control of vasopressin function, in: Disturbances in Body Fluid Osmolality ( T. E. Andreoli, J. J. Grantham, and F. C. Rector, Jr., eds.), pp. 125–148, The American Physiological Society, Bethesda.Google Scholar
  24. 24.
    Baylis, P. H., and Robertson, G. L., 1980, Plasma vasopressin response to hypertonic saline infusion to assess posterior pituitary function, J. R. Soc. Med. 73: 255–260.PubMedGoogle Scholar
  25. 25.
    Brimble, M.J., and Dyball, R. E.J., 1977, Characterization of the responses of oxytocin-and vasopressin-secreting neurones in the supraoptic nucleus to osmotic stimulation, J. Physiol. (London) 271: 253–271.Google Scholar
  26. 26.
    Zerbe, R., Vinicor, F., and Robertson, G. L., 1978, Vasopressin (VP) secretion in man is stimulated by urea and suppressed by glucose, Clin. Res. 26: 315A.Google Scholar
  27. 27.
    McKinley, M. J., Denton, D. A., and Weisinger, R. S., 1978, Sensors for antidiuresis and thirst-Osmoreceptors or CSF sodium detectors?, Brain Res. 141: 89–103.PubMedCrossRefGoogle Scholar
  28. 28.
    Thrasher, T. N., Brown, C. J., Keil, L. C., and Ramsay, D. J., 1980, Thirst and vasopressin release in the dog: An osmoreceptor or sodium receptor mechanism?, Am. J. Physiol. 238: R333 - R339.PubMedGoogle Scholar
  29. 29.
    Olsson, K., and Kolmodin, R., 1974, Dependence of basic secretion of antidiuretic hormone on cerebrospinal fluid [Na], Acta Physiol. Scand. 91: 286–288.PubMedCrossRefGoogle Scholar
  30. 30.
    Rundgren, M., Eriksson, S., and Appelgren, B., 1979, Urea-induced inhibition of antidiuretic hormone (ADH) secretion, Acta Physiol. Scand. 106: 491–492.PubMedCrossRefGoogle Scholar
  31. 31.
    Zerbe, R. L., Miller, J. Z., and Robertson, G. L., 1980, Reproducibility and heritability of vasopressin osmoregulation in humans, Endocrinology 106(Suppl.):78, Abstract 13.Google Scholar
  32. 32.
    Helderman, J. H., Vestal, R. E., Rowe, J. W., Tobin, J. D., Andres, R., and Robertson, G. L., 1978, The response of arginine vasopressin to intravenous ethanol and hypertonic saline in man: The impact of aging, J. Gerontol. 33: 39–47.PubMedCrossRefGoogle Scholar
  33. Durr, J. A., Stamoutsos, B., and Lindheimer, M. D., 1981, Osmoregulation during pregnancy in the rat: Evidence for resetting of the threshold for vasopressin secretion during gestation, J. Clin. Invest.68:337–346.Google Scholar
  34. 34.
    Hytten, F. E., 1968, Physiological changes in early pregnancy, J. Obstet. Gynaecol. Br. Commonw. 75: 1193–1197.PubMedCrossRefGoogle Scholar
  35. 35.
    Robertson, E. G., and Cheyne, G. A., 1972, Plasma biochemistry in relation to oedema of pregnancy, J. Obstet. Gynaecol. Br. Commonw. 79: 769–776.PubMedCrossRefGoogle Scholar
  36. 36.
    Davison, J. M., Calloton, M. B., and Lindheimer, M. D., 1980, Alterations in plasma osmolality (Posen) during human pregnancy, Clin. Res. 28: 442A.Google Scholar
  37. 37.
    Buggy, J., and Johnson, A. K., 1977, Preoptic-hypothalamic periventricular lesions: Thirst deficits and hypernatremia, Am. J. Physiol. 233: R44- R52.Google Scholar
  38. 38.
    Bealer, S. L., Phillips, M. I., Johnson, A. K., and Schmid, P. G., 1979, Anteroventral third ventricle lesions reduce antidiuretic responses to angiotensin II, Am. J. Physiol. 236: E610 - E615.PubMedGoogle Scholar
  39. 39.
    Miller, T. R., Handelman, W. A., Arnold, P. E., McDonald, K. M., Molinoff, P. B., and Schrier, R. W., 1979, Effect of central catecholamine depletion on the osmotic and non-osmotic stimulation of vasopressin (ADH) in the rat, J. Clin. Invest. 64: 1599–1607.PubMedCrossRefGoogle Scholar
  40. 40.
    Hoffman, W. E., Phillips, M. I., and Schmid, P., 1977, The role of catecholamines in central antidiuretic and pressor mechanisms, Neuropharmacology 16: 563–569.PubMedCrossRefGoogle Scholar
  41. 41.
    Sladek, C. D., and Joynt, R. J., 1979, Cholinergic involvement in osmotic control of vasopressin release by the organ-cultured rat hypothalamo-neurohypophyseal system, Endocrinology 105: 367–371.PubMedCrossRefGoogle Scholar
  42. 42.
    Sladek, D. C., and Knigge, K. M., 1977, Cholinergic stimulation of vasopressin release from the rat hypothalamo-neurohypophyseal system in organ culture, Endocrinology 101: 411.PubMedCrossRefGoogle Scholar
  43. 43.
    de Weid, D., and Laszlo, F. A., 1967, Effect of autonomic blocking agents on ADH-release induced by hyperosmoticity, J. Endocrinol. 37: XVI.Google Scholar
  44. 44.
    Bridges, T. E., and Thorn, N. A., 1970, The effect of autonomic blocking agents on vasopressin release in vivo induced by osmoreceptor stimulation, J. Endocrinol. 48: 263.CrossRefGoogle Scholar
  45. 45.
    Milton, A. S.,and Paterson, A. T., 1974, A microinjection study of the control of antidiuretic hormone release by the supraoptic nucleus of the hypothalamus in the rat, J. Physiol. (London) 241: 607.Google Scholar
  46. 46.
    Morris, M., McCann, S. M., and Orias, R., 1977, Role of transmitters in mediating hypothalamic control of electrolyte excretion, Can. J. Physiol. Pharmacol. 55: 1143.PubMedCrossRefGoogle Scholar
  47. 47.
    Gann, D. S., Ward, D. G., and Carlson, D. E., 1978, Neural control of ACTH: A homeostatic reflex, Recent Prog. Horm. Res. 34: 357–396.PubMedGoogle Scholar
  48. 48.
    Sawchenko, P. E., and Swanson, L. W., 1981, Central noradrenergic pathways for the integration of hypothalamic neuroendocrine and autonomic responses, Science 214: 685–687.PubMedCrossRefGoogle Scholar
  49. 49.
    Thames, M. D., and Schmid, P. G., 1979, Cardiopulmonary receptors with vagal afferents tonically inhibit ADH release in the dog, Am. J. Physiol. 237: H299 - H304.PubMedGoogle Scholar
  50. 50.
    Fumoux, F., Czernichow, P., Arnauld, E., Du Pont, J., and Vincent, J. D., 1978, Effect of hypotension induced by sodium nitrocyanoferrate (III) on the release of arginine vasopressin in the unanaesthetized monkey, J. Endocrinol. 78: 449–450.PubMedCrossRefGoogle Scholar
  51. 51.
    Wood, C. E., Shinsako, J., Keil, L. C., Ramsay, D. J., and Dallman, M. F., 1981, Hormonal and hemodynamic responses to 15 ml/kg hemorrhage in conscious dogs: Responses correlate to body temperature, Proc. Soc. Exp. Biol. Med. 167: 15–19.Google Scholar
  52. 52.
    Robertson, G. L., and Rowe, J., 1980, The effect of aging on neurohypophyseal function, Peptides 1 (Suppl. 1): 159–162.CrossRefGoogle Scholar
  53. 53.
    Kannan, H., and Yagi, K., 1978, Supraoptic neurosecretory neurons: Evidence for the existence of converging inputs both from carotid baroreceptors and osmoreceptors, Brain Res. 145: 385–390.PubMedCrossRefGoogle Scholar
  54. 54.
    Bark, H., Le Roith, D., Nyska, M., and Glick, S. M., 1980, Elevations in plasma ADH levels during PEEP ventilation in the dog: Mechanisms involved, Am. J. Physiol. 239: E474 - E481.PubMedGoogle Scholar
  55. 55.
    Wiggins, R. C., Basar, I., Slater, J. D. H., Forsling, M., and Ramage, C. M., 1977, Vasovagal hypotension and vasopressin release, Clin. Endocrinol. 6: 387–393.CrossRefGoogle Scholar
  56. 56.
    Kendler, K. S., Weitzman, R. E., and Fisher, D. A., 1978, The effect of pain on plasma arginine vasopressin concentrations in man, Clin. Endocrinol. 8: 80–94.CrossRefGoogle Scholar
  57. 57.
    Husain, M. K., Manger, W. M., Rock, T. W., Weiss, R. J., and Frantz, A. G., 1979, Vasopressin release due to manual restraint in the rat: Role of body compression and comparison with other stressful stimuli, Endocrinology 104: 641–644.PubMedCrossRefGoogle Scholar
  58. 58.
    Rowe, J. W., Shelton, R. L., Helderman, J. H., Vestal, R. E., and Robertson, G. L., 1979, Influence of the emetic reflex on vasopressin release in man, Kidney Int. 16: 729–735.PubMedCrossRefGoogle Scholar
  59. 59.
    Coutinho, E. M., 1969, Oxytocic and antidiuretic effects of nausea in women, Am. J. Obstet. Gynecol. 105: 127–131.Google Scholar
  60. 60.
    Eversmann, T., Guttsmann, M., Uhlich, E., Ulbrecht, G., von Werder, K., and Scriba, P. C., 1978, Increased secretion of growth hormone, prolactin, antidiuretic hormone, and cortisol induced by the stress of motion sickness, Aviat. Space Environ. Med. January 1978: 53–57.Google Scholar
  61. 61.
    Baylis, P. H., and Heath, D. A., 1977, Plasma-arginine-vasopressin response to insulin-induced hypoglycaemia, Lancet 2: 428–430.PubMedCrossRefGoogle Scholar
  62. 62.
    Baylis, P. H., Zerbe, R. L., and Robertson, G. L., 1981, Arginine vasopressin response to insulin-induced hypoglycemia in man, J. Clin. Endocrinol. Metab. 53: 935–940.PubMedCrossRefGoogle Scholar
  63. 63.
    Baylis, P. H., and Robertson, G. L., 1980, Rat vasopressin in response to insulin-induced hypoglycemia, Endocrinology 107: 1975–1979.PubMedCrossRefGoogle Scholar
  64. 64.
    Thompson, D. A., Campbell, R. G., Lilavivat, U., Welle, S. L., and Robertson, G. L., 1981, Increased thirst and plasma arginine vasopressin levels during 2-deoxy-D-glucose-induced glucoprivation in humans, J. Clin. Invest. 67: 1083–1093.PubMedCrossRefGoogle Scholar
  65. 65.
    Baylis, P. H., and Robertson, G. L., 1980, Vasopressin response to 2-deoxyD-glucose in the Rat, Endocrinology 107: 1970–1974.PubMedCrossRefGoogle Scholar
  66. 66.
    Granberg, P.-O., 1962, Effect of acute hypoxia on renal haemodynamics and water diuresis in man, Scand. J. Clin. Lab. Invest. 14 (Suppl. 63): 5–62.Google Scholar
  67. 67.
    Forsling, M. L., and Rees, M., 1975, Effects of hypoxia and hypercapnia on plasma vasopressin concentration, J. Endocrinol. 67: 62P - 63 P.PubMedGoogle Scholar
  68. 68.
    Anderson, R. J., Pluss, R. G., Berns, A. S., Jackson, J. I., Arnold, P. E., Schrier, R. W., and McDonald, K. M., 1978, Mechanism of effect of hypoxia on renal water function, J. Clin. Invest. 62: 769–777.PubMedCrossRefGoogle Scholar
  69. 69.
    Baylis, P. H., Stockley, R. A., and Heath, D. A., 1977, Effect of acute hypoxaemia on plasma arginine vasopressin in conscious man, Clin. Sci. Mol. Med. 53: 401–404.PubMedGoogle Scholar
  70. 70.
    Claybaugh, J. R., Hansen, J. E., and Wozniak, D. B., 1978, Response of antidiuretic hormone to acute exposure to mild and severe hypoxia in man, J. Endocrinol. 77: 157–160.PubMedCrossRefGoogle Scholar
  71. 71.
    Heyes, M. P., Farber, M. O., Manfredi, F., Robertshaw, D., Weinberger, M., Fineberg, N., and Robertson, G., 1982, Acute effects of hypoxia on renal and endocrine function in normal humans, Am. J. Physiol. 243: R265 - R270.PubMedGoogle Scholar
  72. 72.
    de Bodo, R. C., 1944, The antidiuretic action of morphine and its mechanism, J. Pharmacol. Exp. Ther. 82: 74–85.Google Scholar
  73. 73.
    Duke, H. N., Pickford, M., and Watt, J. A., 1951, The antidiuretic action of morphine: Its site and mode of action in the hypothalamus of the dog, Q. J. Exp. Physiol. 36: 149–158.Google Scholar
  74. 74.
    Giarman, N. J., Mattie, L. R., and Stephenson, W. F., 1953, Studies on the antidiuretic action of morphine, Science 117: 225–226.PubMedCrossRefGoogle Scholar
  75. 75.
    Giarman, N. J., and Condouris, G. A., 1954, The antidiuretic action of morphine and some of its analogues, Arch. Int. Pharmacodyn. 97: 28–33.PubMedGoogle Scholar
  76. 76.
    Schnieden, H., and Blackmore, E. K., 1955, The effect of nalorphine on the antidiuretic action of morphine in rats and men, Br. J. Pharmacol. 10: 45–50.Google Scholar
  77. 77.
    Inturrisi, C. E., and Fujimoto, J. M., 1968, Studies on the antidiuretic action of morphine in the rat, Eur. J. Pharmacol. 2: 301–307.PubMedCrossRefGoogle Scholar
  78. 78.
    Handley, C. A., and Keller, A. D., 1950, Changes in renal function produced by morphine in normal dogs and dogs with diabetes insipidus, J. Pharmacol. Exp. Ther. 99: 33–37.PubMedGoogle Scholar
  79. 79.
    Fujimoto, J. M., 1971, The kidney, in: Narcotic Drugs: Biochemical Pharmacology ( D. H. Clouet, ed.), pp. 366–393, Plenum Press, New York.Google Scholar
  80. 80.
    Hayward, J. N., 1974, Effects of drugs of abuse on motivated behavior and magnocellular neuroendocrine cells, in: Narcotics and the Hypothalamus ( E. Zimmermann and R. George. eds.), pp. 83–93, Raven Press, New York.Google Scholar
  81. 81.
    Miller, M., 1975, Inhibition of ADH release in the rat by narcotic antagonists, Neuroendocrinology 19: 241–251.PubMedCrossRefGoogle Scholar
  82. 82.
    Weitzman, R. E., Fisher, D. A., Minick, S., Ling, N., and Guillemin, R., 1977, 0-Endorphin stimulates secretion of arginine vasopressin in vivo, Endocrinology 101: 1643–1646.Google Scholar
  83. 83.
    Bisset, G. W., Chowdrey, H. S., and Feldberg, W., 1978, Release of vasopressin by enkephalin, Br. J. Pharmacol. 62: 370–371.PubMedCrossRefGoogle Scholar
  84. 84.
    Tseng, L.-F., Loh, H. H., and Li, C. H., 1978, Oh-Endorphin: Antidiuretic effects in rats. Int. J. Pept. Protein Res. 12: 173–176.PubMedCrossRefGoogle Scholar
  85. 85.
    Catlin, D. H., George, R., and Li, C. H., 1978,13-Endorphin: Pharmacologic and behavioral activity in cats after low intravenous doses, Life Sci. 23: 2147–2154.Google Scholar
  86. 86.
    Goldstein, A., 1976, Opioid peptides (endorphines) in pituitary and brain, Science 193: 1081–1086.PubMedCrossRefGoogle Scholar
  87. 87.
    Sar, M., Stumpf, W. E., Miller, R. J., Chang, K.J., and Cuatrecasas, P., 1978, Immunohistochemical localization of enkephalin in rat brain and spinal cord, J. Comp. Neurol. 182: 17–37.Google Scholar
  88. 88.
    Rossier, J., Battenberg, E., Pittman, Q., Bayon, A., Koda, L., Miller, R., Guillemin, R., and Bloom, F., 1979, Hypothalamic enkephalin neurones may regulate the neurohypophysis, Nature (London) 277: 653–655.CrossRefGoogle Scholar
  89. 89.
    Miller, M., 1980, Role of endogenous opioids in neurohypophysial function of man, J. Clin. Endocrinol. Metab. 50: 1016–1020.PubMedCrossRefGoogle Scholar
  90. 90.
    Kamoi, K., White, K., and Robertson, G. L., 1979, Opiates elevate the osmotic threshold for vasopressin (VP) release in rats, Clin. Res. 27: 254A.Google Scholar
  91. 91.
    van Wimersma, Greidanus, T. B., Thody, T. J., Verspaget, H., de Rotte, G. A., Goedemans, H. J. H., Croiset, G., and van Ree, J. M., 1979, Effects of morphine and 0-Endorphin on basal and elevated plasma levels of aMSH and vasopressin, Life Sci. 24: 579–586.CrossRefGoogle Scholar
  92. 92.
    Lord, J. A. H., Waterfield, A. A., Hughes, J., and Kosterlitz, H. W., 1977, Endogenous opioid peptides: Multiple agonists and receptors, Nature (London) 267: 496–499.CrossRefGoogle Scholar
  93. 93.
    Chang, K.-J., and Cuatrecasas, P., 1979, Multiple opiate receptors: Enkephalins and morphine bind to receptors of different specificity, J. Biol. Chem. 254: 2610–2618.PubMedGoogle Scholar
  94. 94.
    Kosterlitz, H. W., Lord, J. A. H., Paterson, S. J., and Waterfield, A. A., 1980, Effects of changes in the structure of enkephalins and of narcotic analgesic drugs on their interactions with IL- and 8-receptors, Br. J. Pharmacol. 68: 333–342.PubMedCrossRefGoogle Scholar
  95. 95.
    Egan, T. M., and North, R. A., 1981, Both and S opiate receptors exist on the same neuron, Science 214: 923–925.PubMedCrossRefGoogle Scholar
  96. 96.
    Aziz, L. A. Forsling, M. L., and Woolf, C. J., 1980, The action of morphine on vasopressin release in the rat, J. Physiol. (London) 300: 24P - 25 P.Google Scholar
  97. 97.
    Brownell, J., del Pozo, E., and Donatsch, P., 1980, Inhibition of vasopressin secretion by a Met-enkephalin (FK 33–824) in humans, Acta Endocrinol. (Copenhagen) 94: 304–308.Google Scholar
  98. 98.
    Grossman, A., Besser, G. M., Milles, J. J., and Baylis, P. H., 1980, Inhibition of vasopressin release in man by an opiate peptide, Lancet 2: 1108–1110.PubMedCrossRefGoogle Scholar
  99. 99.
    Summy-Long, J. Y., Keil, L. C., Deen, K., and Severs, W. B., 1981, Opiate regulation of angiotensin-induced drinking and vasopressin release, J. Pharmacol. Exp. Ther. 217: 630–637.PubMedGoogle Scholar
  100. 100.
    Iversen, L. L., Iversen, S. D., and Bloom, F. E., 1980, Opiate receptors influence vasopressin release from nerve terminals in rat neurohypophysis, Nature (London) 284: 350–351.CrossRefGoogle Scholar
  101. 101.
    Clarke, G., Lincoln, D. W., and Wood, P., 1980, Inhibition of vasopressin neurones by intraventricular morphine, J. Physiol (London) 303:59P:-60P.Google Scholar
  102. 102.
    Knepel, W., Nutto, D., Anhut, H., and Hertting, G., 1980, Naloxone promotes stimulus-evoked vasopressin release in vivo, Eur. J. Pharmacol. 65: 449–450.PubMedCrossRefGoogle Scholar
  103. 103.
    Lightman, S. L., and Forsling, M. L., 1980, Evidence for endogenous opioid control of vasopressin release in man, J. Clin. Endocrinol. Metab. 50: 569–571.PubMedCrossRefGoogle Scholar
  104. 104.
    Oiso, Y., and Robertson, G. L., 1982, Role of endogenous opiates in mediating ethanol-induced suppression of vasopressin, Proceedings of the 64th meeting of the Endocrine Society Abst. 751: 267.Google Scholar
  105. 105.
    Huidobro-Toro, J. P., 1980, Antidiuretic effect of 0-endorphin and morphine in Brattleboro rats: Development of tolerance and physical dependence after chronic morphine treatment, Br. J. Pharmacol. 71: 51–56.PubMedGoogle Scholar
  106. 106.
    Cadnapaphornchal, P., Boykin, J. L., Berl, T., McDonald, K. M., and Schrier, R. W., 1974, Mechanism of effect of nicotine on renal water excretion, Am. J. Physiol. 227: 1216–1220.Google Scholar
  107. 107.
    Bisset, G. W., Feldberg, W., Guertzenstein, P. G., and Silva, M. R. E., Jr., 1975, Vasopressin release by nicotine: The site of action, Br. J. Pharmacol. 54: 463–474.CrossRefGoogle Scholar
  108. Cates, J. E., and Garrold, O., 1951, The effect of nicotine on urinary flow in diabetes insipidus, Clin. Sci. 10:145.Google Scholar
  109. Lewis, A. A. G., and Chalmers, T. M., 1951, A nicotine test for the investigation of diabetes insipidus, Clin. Sci. 10:137.Google Scholar
  110. 110.
    Dingman, J. F., Benirschke, K., and Thorn, G. W., 1957, Studies of neurohypophyseal function in man, Am. J. Med. 23: 226.PubMedCrossRefGoogle Scholar
  111. 111.
    Pullen, Q. T., Clappison, B. H., and Johnston, C. I., 1979, Plasma vasopressin and human neurophysin in physiological and pathological states associated with changes in vasopressin secretion, J. Clin. Endocrinol. Metab. 49: 580.CrossRefGoogle Scholar
  112. 112.
    Robinson, A. G., 1975, Isolation, assay and secretion of individual human neurophysins, J. Clin. Invest. 55: 360.PubMedCrossRefGoogle Scholar
  113. 113.
    Rowe, J. W., Kilgore, A., and Robertson, G. L., 1980, Evidence in man that cigarette smoking induces vasopressin release via an airway-specific mechanism, J. Clin. Endocrinol. Metab. 51: 170 - -172.PubMedCrossRefGoogle Scholar
  114. 114.
    Pokracki, F. J., Robinson, A. G., and Seif, S. M., 1981, Chlorpropamide effect: Measurement of neurophysin and vasopressin in humans and rats, Metabolism 30: 72 - -78.PubMedCrossRefGoogle Scholar
  115. 115.
    Stephens, W. P., Coe, J. Y., and Baylis, P. H., 1978, Plasma arginine vasopressin concentrations and antidiuretic action of carbamazepine, Br. Med. J. 1: 1445 - -1447.PubMedCrossRefGoogle Scholar
  116. 116.
    Thomas, T. H., Ball, S. G., Wales, J. K., and Lee, M. R., 1978, Effect of carbamazepine on plasma and urine arginine-vasopressin, Clin. Sci. Mol. Med. 54: 419–424.PubMedGoogle Scholar
  117. 117.
    Meinders, A. F., Cejka, V., and Robertson, G. L., 1974, The antidiuretic action of carbamazepine in man, Clin. Sci. Mol. Med. 47: 289–299.PubMedGoogle Scholar
  118. Smith, N. J., Espir, M. L. E., and Baylis, P. H., 1977, Raised plasma arginine vasopressin concentration in carbamazepine-induced water intoxication, Br. Med. J.1:804.Google Scholar
  119. 119.
    Miller, P. D., Dubovsky, S. L., McDonald, K. M., Katz, F. H., Robertson, G. L., and Schrier, R. W., 1979, Central, renal and adrenal effects of lithium in man, Am. J. Med. 66: 797–803.PubMedCrossRefGoogle Scholar
  120. 120.
    Padfield, P. L., Park, S. J., Morton, J. J., and Braidwood, A. E., 1977, Plasma levels of antidiuretic hormone in patients receiving prolonged lithium therapy, Br. J. Psychiatry 130: 144–147.PubMedCrossRefGoogle Scholar
  121. 121.
    Humphreys, M. H., Reid, I. A., and Chou, L. Y. N., 1975, Suppression of antidiuretic hormone secretion by clonidine in the anesthetized dog, Kidney Int. 7: 405–412.PubMedCrossRefGoogle Scholar
  122. 122.
    Reid, I. A., Nolan, P. L., Wolf, J. A., AND Keil, L. C. 1979, Suppression of vasopressin secretion by clonidine: Effect of ct-adrenoceptor antagonists, Endocrinology 104: 1403–1406.PubMedCrossRefGoogle Scholar
  123. 123.
    Kimura, T., Share, L., Wang, B. C., and Crofton, J. T., 1981, The role of central adrenoreceptors in the control of vasopressin release and blood pressure, Endocrinology 108: 1829–1836.PubMedCrossRefGoogle Scholar
  124. 124.
    Sowers, J. R., Hershman, J. M., Skowsky, W. R., and Carlson, H. E., 1976, Effect of TRH on serum arginine vasopressin in euthyroid and hypothyroid subjects, Norm. Res. 7: 232–237.Google Scholar
  125. 125.
    Oliver, C., Eskay, R. I., Ben Jonathan, N., and Porter, J. C., 1974, Distribution and concentration of TRH in the rat brain, Endocrinology 95: 540–546.PubMedCrossRefGoogle Scholar
  126. 126.
    Jackson, I. M. D., and Reichlin, S., 1974, Thyrotropin-releasing hormone (TRH): Distribution in hypothalamic and extrahypothalamic brain tissues of mammalian and submammalian chordates, Endocrinology 95: 854–861.PubMedCrossRefGoogle Scholar
  127. 127.
    Skowsky, W. R., Swan, L., and Smith, P., 1979, Effects of sex steroid hormones on arginine vasopressin in intact and castrated male and female rats, Endocrinology 104: 105–108.PubMedCrossRefGoogle Scholar
  128. 128.
    Legros, L. L., Govaerts, A., Demoulin, A., and Franchimont, P., 1973, Interactions entre un Derive Progestalif et l’Ethinyl Oestradiol sur l’Elimination Urinaire de Neurophysine d’Ocytocine et de Vasopressine Immunoreactives et sur le Taux de Neurophysine Serique 1 et 11 chez l’Homme Normal, C. R. Soc. Biol. 167: 1668.Google Scholar
  129. 129.
    Ukai, M., Nagase, T., Hirohashi, M., and Yanaihara, N., 1981, Antidiuretic activities of substance P and its analogs, Experientia 37: 521–523.PubMedCrossRefGoogle Scholar
  130. 130.
    Jamison, R. L., and Robertson, C. R., 1979, Recent formulations of the urinary concentrating mechanism: A status report, Kidney Int. 16: 537–545.PubMedCrossRefGoogle Scholar
  131. 131.
    Handler, J. S., and Orloff, J., 1981, Antidiuretic hormone, Annu. Rev. Physiol. 43: 611–624.PubMedCrossRefGoogle Scholar
  132. 132.
    Dousa, T. P., and Valtin, H., 1976, Cellular actions of vasopressin in the mammalian kidney, Kidney Int. 10: 46–63.Google Scholar
  133. Bia, M. J., DeWitt, S., and Forrest, J. N., Jr., 1979, Dissociation between plasma, urine and renal papillary cyclic AMP content following vasopressin and DDAVP, Am. J. Physiol.237:F218—F225.Google Scholar
  134. 134.
    Bell, N. H., Clark, C. M., Jr., Avery, S., Sinha, T., Trygstad, C. W., and Allen, D. 0., 1974, Demonstration of a defect in the formation of adenosine 3’, 5’-monophosphate in vasopressin resistant diabetes insipidos, Pediatr. Res. 8: 223–230.Google Scholar
  135. 135.
    Beck, T. R., and Dunn, M. J., 1981, The relationship of antidiuretic hormone and renal prostaglandins, Miner. Electrolyte Metab. 6: 46–59.Google Scholar
  136. 136.
    Beck, T. R., Hassid, A., and Dunn, M. J., 1980, The effect of arginine vasopressin and its analog on the synthesis of prostaglandin E2 by rat renal medullary interstitial cells in culture, J. Pharmacol. Exp. Ther. 215: 15–19.Google Scholar
  137. 137.
    Dunn, M. J., Kinter, L. B., Reinier, B., III, Shier, D., Greeley, H. P., and Valtin, H., 1980, Interaction of vasopressin and renal prostaglandins in the homozygous diabetes insipidus rat, Adv. Prostaglandin Thromboxane Res. 7: 1009–1015.PubMedGoogle Scholar
  138. 138.
    Burch, R. M., Knapp, D. R., and Halushka, P. V., 1979, Vasopressin stimulates thromboxane synthesis in the toad urinary bladder: Effects of imidazole, J. Pharmacol. Exp. Ther. 210: 344–348.PubMedGoogle Scholar
  139. 139.
    Carretero, O. A., and Scicli, A. G., 1976, Renal kallikrein: Its localization and possible role in renal function, Fed. Proc. 35: 194–198.PubMedGoogle Scholar
  140. 140.
    Levinsky, N. G., 1979, The renal kallikrein—kinin system, Circ. Res. 44: 441–451.PubMedCrossRefGoogle Scholar
  141. Scicli, A. G., Gandolfi, R., and Carretero, O. A., 1978, Site of formation of kinins in the dog nephron, Am. J. Physiol.234:F36—F40.Google Scholar
  142. 142.
    Robertson, G. L., and Conder, M. L., 1980, The regulation of urinary kinin excretion, in:Hormonal Regulation of Sodium Excretion (B. Lichardus, R. W. Schrier, and J. Poney, eds.), pp. 239–248, Elsevier/North-Holland, Amsterdam.Google Scholar
  143. 143.
    Carvounis, C. P., Carvounis, G., and Abbett, L. A., 1981, Role of the endogenous kallikrein—kinin system in modulating vasopressin-stimulated water flow and urea permeability in the toad urinary bladder, J. Clin. Invest. 67: 1792–1796.PubMedCrossRefGoogle Scholar
  144. 144.
    Furtado, M. R. F., 1971, Inhibition of the permeability response to vasopressin and oxytocin in the toad bladder: Effect of bradykinin, kallidin, eleodosin and physalamine, J. Membr. Biol. 4: 167–178.Google Scholar
  145. 145.
    Zusman, R. M., and Keiser, H. R., 1977, Prostaglandin biosynthesis by rabbit renomedullary interstitial cells in tissue culture: Stimulation by angiotensin II, bradykinin, and arginine vasopressin, J. Clin. Invest. 60: 215–233.PubMedCrossRefGoogle Scholar
  146. 146.
    Humes, H. D., Simmons, C. F., Jr., and Brenner, B. M., 1980, Effect of verapamil on the hydroosmotic response to antidiuretic hormone in toad urinary bladder, Am. J. Physiol. 239: F250 - F257.PubMedGoogle Scholar
  147. 147.
    Levine, S. D., Kachadorian, W. A., Levin, D. N., and Schlondorff, D., 1981, Effects of trifluoperazine on function and structure of toad urinary bladder, J. Clin. Invest. 67: 662–672.PubMedCrossRefGoogle Scholar
  148. 148.
    Beauwens, R., and Rentmeesters, M., 1981, Rose of calmodulin in antidiuretic hormone mediated water transport, Biochem. Biophys. Res. Commun. 99: 491–495.PubMedCrossRefGoogle Scholar
  149. 149.
    Humes, H. D., Simmons, C. F., Jr., and Brenner, B. M., 1980, Interaction between antidiuretic and parathyroid hormones on urine concentration, Am. J. Physiol. 239: F244 - F249.PubMedGoogle Scholar
  150. 150.
    Reid, I. A., and Rose, J. C., 1977, An intrarenal effect of somatostatin on water excretion, Endocrinology 100: 782–785.PubMedCrossRefGoogle Scholar
  151. 151.
    Forrest, J. N., Jr., Reichlin, S., and Goodman, D. B. P., 1980, Somatostatin: An endogenous peptide in the toad urinary bladder inhibits vasopressinstimulated water flow, Proc. Natl. Acad. Sci. USA 77: 4984–4987.PubMedCrossRefGoogle Scholar
  152. 152.
    Sawyer, W. H., Pang, P. K. T., Seto, J., McEnroe, M., Lammek, B., and Manning, M., 1981, Vasopressin analogs that antagonize antidiuretic responses by rats to the antidiuretic hormone, Science 212: 49–51.PubMedCrossRefGoogle Scholar
  153. 153.
    Edwards, B. R., Gellai, M., and Valtin, H., 1980, Concentration of urine in the absence of ADH with minimal or no decrease in GFR, Am. J. Physiol. 239: F84 - F91.PubMedGoogle Scholar
  154. 154.
    Rowe, L. W., 1929, Studies on oxytocin and vasopressin: Pressor action, Endocrinology 13: 205.CrossRefGoogle Scholar
  155. 155.
    Grabiel, A., and Glendy, R. E., 1951, Circulatory effects following the intravenous administration of pitressin in normal persons and in patients with hypertension and agina pectoris, Am. Heart J. 21: 481.CrossRefGoogle Scholar
  156. 156.
    Wagner, H. N., and Braunwald, E., 1956, The pressor effect of the antidiuretic principle of the posterior pituitary in orthostatic hypotension, J. Clin. Invest. 35: 1412.PubMedCrossRefGoogle Scholar
  157. 157.
    Laycock, J. F., Penn, W., Shirley, D. G., and Walter, S. J., 1979, The role of vasopressin in blood pressure regulation immediately following acute haemorrhage in the rat, J. Physiol. (London 296: 267–275.Google Scholar
  158. 158.
    Altura, B. M., 1980, Evidence that endogenous vasopressin plays a protective role in circulatory shock: Role for reticuloendothelial system using Brattleboro rats, Experientia 36: 1080–1082.PubMedCrossRefGoogle Scholar
  159. 159.
    Cowley, A. W., Jr., Switzer, S. J., and Guinn, M. M., 1980, Evidence and quantification of the vasopressin arterial pressure control system in the dog, Circ. Res. 46: 58–67.PubMedCrossRefGoogle Scholar
  160. 160.
    Montani, J.-P., Liard, J.-F., Schoun, J., and Mohring, J., 1980, Hemodynamic effects of exogenous and endogenous vasopressin at low plasma concentrations in conscious dogs, Circ. Res. 47: 346–355.PubMedCrossRefGoogle Scholar
  161. 161.
    Cowley, A. W., Jr., Monos, E.,and Guyton, A.C., 1974, Interaction of vasopressin and the baroreceptor reflex system in the regulation of arterial blood pressure in the dog. Circ. Res. 24: 505–514.Google Scholar
  162. 162.
    Malayan, S. A., Ramsay, D. J., Keil, L. C., and Reid, I. A., 1980, Effects of plasma increases in plasma vasopressin concentration on plasma renin activity, blood pressure, heart rate, and plasma corticosteroid concentration in conscious dogs, Endocrinology 107: 1899–1904.PubMedCrossRefGoogle Scholar
  163. 163.
    Mohring, J., Glanzer, K., Maciel, J. A., Jr., Dusing, R., Kramer, H. J., Arbogast, R., and Koch-Weser, J., 1980, Greatly enhanced pressor response to antidiuretic hormone in patients with impaired cardiovascular reflexes due to idiopathic orthostatic hypotension, J. Cardiovasc. Pharmacol. 2: 367–378.PubMedCrossRefGoogle Scholar
  164. 164.
    Ciriello, J., and Calaresu, F. R., 1980, Role of paraventricular and supraoptic nuclei in central cardiovascular regulation in the cat, Am. J. Physiol. 81: R137 — R142.Google Scholar
  165. 165.
    Hems, D. A., Whitton, P. D., and Ma, G. Y., 1975, Metabolic activities of vasopressin, glucagon and adrenalin in the intact rat, Biochim. Biophys. Acta 411: 155.PubMedCrossRefGoogle Scholar
  166. 166.
    Whitton, P. A., Rodrigues, L. M., and Hems, D. A., 1978, Stimulation by vasopressin, angiotensin and oxytocin of gluconeogenesis in hepatocyte suspensions, Biochem. J. 176: 893–898.PubMedGoogle Scholar
  167. 167.
    Williamson, D. H., Ilic, V., Tordoff, A. F. C., and Ellington, E. V., 1980, Interactions between vasopressin and glucagon on ketogenesis and oleate metabolism in isolated hepatocytes from fed rats, Biochem. J. 186: 621–624.PubMedGoogle Scholar
  168. 168.
    Schapiro, H., and Britt, L. G., 1972, The action of vasopressin on the gastrointestinal tract: A review of the literature, Am. J. Dig. Dis. 17: 649–667.Google Scholar
  169. 169.
    Schapiro, H., 1975, Inhibitory action of antidiuretic hormone on canine pancreatic exocrine flow, Am. J. Dig. Dis. 20: 853–857.PubMedCrossRefGoogle Scholar
  170. 170.
    Dornhorst, A., Carlson, D. E., Seif, S. M., Robinson, A. G., Zimmerman, E. A., and Gann, D. S., 1981, Control of adrenocorticotropin and vasopressin by the supraoptic and paraventricular nuclei, Endocrinology 108: 1420–1424.PubMedCrossRefGoogle Scholar
  171. 171.
    Arimura, A., Saito, T., Bowers, C. Y., and Schally, A. V., 1967, Pituitary—adrenal activation in rats with hereditary hypothalamic diabetes insipidus, Acta Endocrinol. (Copenhagen) 54: 155–165.Google Scholar
  172. 172.
    McCann, S. M., Antunes-Rodrigues, J., Nallar, R., and Valtin, H., 1966, Pituitary adrenal function in the absence of vasopressin, Endocrinology 79: 1058–1064.PubMedCrossRefGoogle Scholar
  173. 173.
    Karteszi, M., Stark, E., Rappay, G., Laszlo, F. A., and Makara, G. B., 1981, Corticoliberin activity of rat neurohypophysis is distinct from vasopressin, Am. J. Physiol. 240: E689 — E693.PubMedGoogle Scholar
  174. 174.
    Buckingham, J. C., and Leach, J. H., 1980, Hypothalamo-pituitary-adrenocortical function in rats with inherited diabetes insipidus, J. Physiol. (London) 305: 397–404.Google Scholar
  175. 175.
    Knepel, W., Anhut, H., Nutto, D., and Hertting, G., 1980, Evidence that vasopressin is involved in the isoprenaline-induced 13-endorphin release, Eur. J. Pharmacol. 68: 359–363.PubMedCrossRefGoogle Scholar
  176. 176.
    Raichle, M. E., and Grubb, R. L., Jr., 1978, Regulation of brain water permeability by centrally-released vasopressin, Brain Res. 143: 191–194.PubMedCrossRefGoogle Scholar
  177. 177.
    Barker, J. L., 1977, Physiological roles of peptides in the nervous system, in: Peptides in Neurobiology ( A. Gainer, ed.), pp. 295–343, Plenum Press, New York.CrossRefGoogle Scholar
  178. 178.
    de Wied, D., 1976, Hormonal influences on motivation, learning, and memory processes, Hosp. Pract. January 1976: 123–131.Google Scholar
  179. 179.
    Walter, R., Hoffman, P. L., Flexner, J. B., and Flexner, L. B., 1975, Neurohypophyseal hormones, analogs, and fragments; Their effect on puromycin-induced amnesia, Proc. Natl. Acad. Sci. USA 72: 4180–4184.PubMedCrossRefGoogle Scholar
  180. 180.
    Gold, P. W., Goodwin, F. K., Ballenger, J. C., Post, R. M., Weingartner, H., and Robertson, G. L., 1981, Central vasopressin function in affective illness, Int. J. Ment. Health 9: 91–107.Google Scholar
  181. 181.
    Miller, M., Dalakos, T., Moses, A. M., Fellerman, H., and Streeten, D. H. P., 1970, Recognition of partial defects in antidiuretic hormone secretion, Ann. Intern. Med. 73: 721–729.PubMedGoogle Scholar
  182. 182.
    Streeten, D. H. P., Moses, A. M., and Miller, M., 1980, Disorders of neurohypophysis, in: Harrison’s Principles of Internal Medicine ( K. J. Isselbacher, R. D. Adams, E. Braunwald, R. G. Petersdorf, and J. D. Wilson, eds.) 9th ed., pp. 1684–1694, McGraw—Hill, New York.Google Scholar
  183. 183.
    Shimizu, S., and Hoshimo, M., 1978, Application of vasopressin radioimmunoassay to clinical study: Role of vasopressin in hypo-and hypernatremia and some other disorders of water metabolism, Contrib. Nephrol. 9: 42–60.PubMedGoogle Scholar
  184. 184.
    Baylis, P. H., Gaskill, M. B., and Robertson, G. L., 1981, Vasopressin secretion in primary polydipsia and cranial diabetes insipidus, Q. J. Med. 50: 345–358.Google Scholar
  185. 185.
    Zerbe, R. L., Baylis, P. H., and Robertson, G. L., 1981, Vasopressin function in clinical disorders of water balance, in: Butterworth’s International Medical Review Series, Clinical Endocrinology, Volume 1 ( G. L. Robertson and C. G. Beardwell, eds.), pp. 297–329, Butterworths, London.Google Scholar
  186. 186.
    Zerbe, R. L., and Robertson, G. L., 1981, A comparison of plasma vasopressin measurements with a standard indirect test in the differential diagnosis of polyuria, N. Engl. J. Med. 305: 1539–1546.PubMedCrossRefGoogle Scholar
  187. 187.
    Block, L. H., Locher, R., Tenscheri, W., Siegenthaler, W., Hofmann, T., Mettler, R., and Vetter, W., 1981, 125I-8-Larginine vasopressin binding to human mononuclear phagocytes, J. Clin. Invest. 68: 374–381.Google Scholar
  188. 188.
    Laczi, F., Mezel, G., Julesz, J., and Laszlo, F. A., 1980, Effects of vasopressin analogues (DDAVP, DVDAVP) in the form of sublingual tablets in central diabetes insipidus, Int. J. Clin. Pharmacol. Ther. Toxicol. 18: 63–68.Google Scholar
  189. 189.
    Zusman, R. W., Keiser, H. R., and Handler, J. S., 1977, Inhibition of vasopressin-stimulated prostaglandin E biosynthesis by chlorpropamide in the toad urinary bladder, J. Clin. Invest. 60: 1348–1353.PubMedCrossRefGoogle Scholar
  190. 190.
    Halter, J. B., Goldberg, A. P., Robertson, G. L., and Porte, D., Jr., 1977, Selective osmoreceptor dysfunction in the syndrome of chronic hypernatremia, J. Clin. Endocrinol. Metab. 44: 609–616.PubMedCrossRefGoogle Scholar
  191. 191.
    Nandi, M., and Harrington, A. R., 1978, Successful treatment of hypernatremic thirst deficiency with chlorpropamide, Clin. Nephrol. 10: 90–95.PubMedGoogle Scholar
  192. 192.
    Schaad, U., Vassella, F., Zuppinger, K., and Oetliker, 0., 1979, Hypodipsia–hypernatremia syndrome, Heiv. Paediatr. Acta 34: 63–76.Google Scholar
  193. 193.
    Kimura, T., Matsui, K., Ota, K., and Yoshinaga, K., 1979, Hypothalamic hypernatremia due to volume-dependent ADH release, and its treatment with carbamazepine and clofibrate, Tohoku J. Exp. Med. 127: 101–111.PubMedCrossRefGoogle Scholar
  194. 194.
    Rosansky, S. J., and Nidus, B. D., 1981, Volume receptor control of ADH release in essential hypernatremia, NY State J. Med. March 1981: 351–356.Google Scholar
  195. 195.
    AvRuskin, T. W., Tang, S. C., and Juan, C., 1981, Essential hypernatremia, antidiuretic hormone and neurophysin secretion: Response to chlorpropamide, Accta Endocrinol (Copenhagen) 96: 145–153.Google Scholar
  196. 196.
    Bode, H. H., and Crawford, J. D., 1969, Nephrogenic diabetes insipidus in North America—The Hopewell hypothesis, N. Engl. J. Med. 280: 750–754.PubMedCrossRefGoogle Scholar
  197. 197.
    Robertson, G. L., and Scheidler, J. A., 1981, A newly recognized variant of familial nephrogenic diabetes insipidus distinguished by partial resistance to vasopressin (type II), Clin. Res. 29: 555A.Google Scholar
  198. 198.
    Singer, I. and Forrest, J. N., Jr., 1976, Drug-induced states of nephrogenic diabetes insipidus, Kidney Int. 10:82–95.Google Scholar
  199. 199.
    Barbour, G. L., Straub, K. D., O’Neal, B. L., and Leatherman, J. W., 1979, Vasopressin-resistant nephrogenic diabetes insipidus: A result of amphotericin B therapy, Arch. Intern. Med. 139: 86–88.PubMedCrossRefGoogle Scholar
  200. 200.
    Lee, R. V., Jampol, L. M., and Brown, W. V., 1971, Nephrogenic diabetes insipidus and lithium intoxication—Complications of lithium carbonate therapy, N. Engl. J. Med. 284: 94–94, 1971.Google Scholar
  201. 201.
    Forrest, J. N., Jr., Cohen, A. D., Torretti, J., Himmelhoch, J. M., and Epstein, F. H., 1974, On the mechanism of lithium-induced diabetes insipidus in man and the rat, J. Clin. Invest. 53: 1115–1122.PubMedCrossRefGoogle Scholar
  202. 202.
    Dousa, T. P., and Barnes, L. D., 1978, Lithium-induced diuretic effect of antidiuretic hormone in rats, Am. J. Physiol. 231: 1754–1759.Google Scholar
  203. 203.
    Christensen, S., 1980, DDAVP (1-desamino-8-D-arginine-vasopressin) treatment of lithium-induced polyuria in the rat, Scand. J. Clin. Lab. Invest. 40: 151–157.PubMedCrossRefGoogle Scholar
  204. 204.
    Hestbech, J., Hansen, H. E., Amdisen, A., and Olsen, S., 1977, Chronic renal lesions following long-term treatment with lithium, Kidney Int. 12: 205–213.PubMedCrossRefGoogle Scholar
  205. 205.
    Feibusch, J., Barbosa-Saldivar, J. L., Bernstein, R. S., and Robertson, G. L., 1980, Tumor-associated nephrogenic diabetes insipidus, Ann. Intern. Med. 92: 797–798.PubMedGoogle Scholar
  206. 206.
    Cooke, C. R., Turin, M. D., and Walker, W. G., 1979, The syndrome of inappropriate antidiuretic hormone secretion (SIADH): Pathophysiologic mechanisms in solute and volume regulation, Medicine (Baltimore) 58: 240–251.Google Scholar
  207. 207.
    Zerbe, R., Stropes, L., and Robertson, G. L., 1980, Vasopressin function in the syndrome of inappropriate antidiuresis, Annu. Rev. Med. 31: 315–327.PubMedCrossRefGoogle Scholar
  208. 208.
    Fyhrquist, F., Holmberg, G., Perheentupa, J., and Wallenius, M., 1977, Inappropriate secretion of antidiuretic hormone, hypertension, and hypoplastic corpus callosum, J. Clin. Endocrinol. Metab. 45: 691–694.PubMedCrossRefGoogle Scholar
  209. 209.
    Burgar, P. J., Norenberg, N. D., and Yarnell, P. R., 1977, Hyponatremia and central pontine myelinoysis, Neurology 27: 223–228.CrossRefGoogle Scholar
  210. 210.
    Whitaker, M. D., McArthur, R. G., Corenblum, B., Davidman, M., and Haslam, R. H., 1979, Idiopathic, sustained, inappropriate secretion of ADH with associated hypertension and thirst, Am. J. Med. 67: 511–515.PubMedCrossRefGoogle Scholar
  211. 211.
    Baylis, P. H., and Robertson, G. L., 1979, Absent baroregulation of vasopressin (VP) with hypertension and inappropriate antidiuresis (SIADH), Clin. Res. 27: 447A.Google Scholar
  212. 212.
    Robertson, G. L., 1978, Cancer and inappropriate antidiuresis, in: Biological Markers of Neoplasia: Basic and Applied Aspects ( R. W. Rudden, ed.) pp. 277–293, Elsevier North-Holland, Amsterdam.Google Scholar
  213. 213.
    Perks, W. H., Crow, J. C., and Green, M., 1978, Mesothelioma associated with the syndrome of inappropriate secretion of antidiuretic hormone, Am. Rev. Respir. Dis. 117: 780–791.Google Scholar
  214. 214.
    Robertson, G. L., 1980, Psychogenic polydipsia and inappropriate antidiuresis, Arch. Intern. Med. 140: 1574–1575.PubMedCrossRefGoogle Scholar
  215. 215.
    Raskind, M. A., Orenstein, H., and Christopher, T. G., 1975, Acute psychosis, increased water ingestion and inappropriate antidiuretic hormone secretion, Am. J. Psychiatry 132: 907–910.PubMedGoogle Scholar
  216. 216.
    Rose, C. J., and Perez-Cruet, J., 1979, Incidence and morbidity of self-induced water intoxication in state mental hospital patients, Am. J. Psychiatry 136: 221–222.Google Scholar
  217. 217.
    Rosenbaum, J. F., Rothman, J. S., and Murray, G. B., 1979, Psychosis and water intoxication, J. Clin. Psychiatry 40: 287–291.PubMedGoogle Scholar
  218. 218.
    Jose, C. J., and Evenson, R. C., 1980, Antecedents of self-induced water intoxication, J. Nerv. Ment. Dis. 168: 498–500.PubMedCrossRefGoogle Scholar
  219. 219.
    Smith, W. O., and Clark, M. J., 1980, Self-induced water intoxication in schizophrenic patients, Am. J. Psychiatry 137: 1055–1060.PubMedGoogle Scholar
  220. 220.
    Hariprasad, M. K., Eisinger, R. P., Nadler, I. M., Padmanabhan, C. S., and Nidus, B. D., 1980, Hyponatremia in psychogenic polydipsia, Arch. Intern. Med. 140: 1639–1642.PubMedCrossRefGoogle Scholar
  221. 221.
    Rendell, M., McGrane, D., and Cuesta, M., 1978, Fatal compulsive water drinking, J. Am. Med. Assoc. 240: 2557–2559.CrossRefGoogle Scholar
  222. 222.
    Skowsky, W. R., and Kikuchi, T. A., 1978, The role of vasopressin in the impaired water excretion of myxedema, Am. J. Med. 64: 613–621.PubMedCrossRefGoogle Scholar
  223. 223.
    Waters, A. K., 1978, Increased vasopressin excretion in patients with hypothyroidism, Acta Endocrinol (Copenhagen) 88: 285–290.Google Scholar
  224. 224.
    Macaron, C., and Famuyiwa, 0., 1978, Hyponatremia of hypothyroidism: Appropriate suppression of antidiuretic hormone levels, Arch. Intern. Med. 138: 820–822.PubMedCrossRefGoogle Scholar
  225. Robertson, G. L., 1979, The physiopathology of ADH secretion, in: Clinical Neuroendocrinology: A Pathophysiological Approach (G. Tolis, J. B. Martin, F. Naftolin, eds.) pp. 247–260, Raven Press, New York.Google Scholar
  226. 226.
    Bode, U., Seif, S. M., and Levine, A. S., 1980, Studies on the antidiuretic effect of cyclophosphamide: Vasopressin release and sodium excretion, Med. Pediatr. Oncol. 8: 295–303.PubMedCrossRefGoogle Scholar
  227. 227.
    Zusman, R. M., Vinci, J. M., Bowden, R. E., Horwitz, D., and Keiser, H. R., 1979, Effect of indomethacin and adrenocorticotrophic hormone on renal function in man: An experimental model of inappropriate antidiuresis, Kidney Int. 15: 62–70.PubMedCrossRefGoogle Scholar
  228. 228.
    Nelson, P. B., Seif, S. M., Mardon, J. C., and Robinson, A. G., 1981, Hyponatremia in intracranial disease: Perhaps not the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) J. Neurosurg. 55: 938 - -941.PubMedCrossRefGoogle Scholar
  229. 229.
    Kleeman, C. R., Maxwell, M. H., and Rockney, R. E., 1958, Mechanisms of impaired water excretion in adrenal and pituitary insufficiency. 1. The role of altered glomerular filtration rate and solute excretion, J. Clin. Invest. 37: 1799–1808.PubMedCrossRefGoogle Scholar
  230. 230.
    Green, H. H., Harrington, A. R., and Valtin, H., 1970, On the role of antidiuretic hormone in the inhibition of acute water diuresis in adrenal insufficiency and the effects of gluco-and mineralocorticoids in reversing the inhibition, J. Clin. Invest. 49: 1724–1736.PubMedCrossRefGoogle Scholar
  231. 231.
    Kleeman, C. R., Czaczkes, J. W., and Cutler, R., 1964, Mechanisms of impaired water excretion in adrenal and pituitary insufficiency. IV. Antidiuretic hormone in primary and secondary adrenal insufficiency, J. Clin. Invest. 43: 1641–1648.PubMedCrossRefGoogle Scholar
  232. 232.
    Gill, J. R., Gann, D. S., and Bartter, F. C., 1962, Restoration of water diuresis in Addisonian patients by expansion of the volume of extracellular fluid, J. Clin. Invest. 41: 1078–1085.PubMedCrossRefGoogle Scholar
  233. 233.
    Ackerman, G. L., and Miller, C. L., 1970, Role of hypovolemia in the impaired water diuresis of adrenal insufficiency, J. Clin. Endocrinol. Metab. 30: 252–258.PubMedCrossRefGoogle Scholar
  234. 234.
    Ufferman, R. C., and Schrier, R. W., 1972, Importance of sodium intake and mineralocorticoid hormone in the impaired water excretion in adrenal insufficiency, J. Clin. Invest. 51: 1639–1646.PubMedCrossRefGoogle Scholar
  235. 235.
    Boykin, J., DeTorrente, A., Erickson, A., Robertson, G., and Schrier, R. W., 1978, Role of plasma vasopressin in impaired water excretion of glucocorticoid deficiency, J. Clin. Invest. 62: 738–744.PubMedCrossRefGoogle Scholar
  236. 236.
    Seif, S. M., Robinson, A. G., Zimmerman, E. A., and Wilkins, J., 1978, Plasma neurophysin and vasopressin in the rat: Response to adrenalectomy and steroid replacement, Endocrinology 103: 1009–1015.PubMedCrossRefGoogle Scholar
  237. 237.
    Boykin, J., DeTorrente, A., Robertson, G. L., Erickson, A., and Schrier, R. W., 1979, Persistent plasma vasopressin levels in the hypoosmolar state associated with mineralocorticoid deficiency, Miner. Electrolyte Metab. 2: 310–315.Google Scholar
  238. 238.
    Mandell, I. N., DeFronzo, R. A., Robertson, G. L., and Forrest, J. N., Jr., 1980, Role of plasma arginine vasopressin in the impaired water diuresis of isolated glucocorticoid deficiency in the rat, Kidney Int. 17: 186–195.PubMedCrossRefGoogle Scholar
  239. 239.
    Linas, S. L., Berl, T., Robertson, G. L., Aisenbray, G. A., Schrier, R. W., and Anderson, R. J., 1980, Role of vasopressin in the impaired water excretion of glucocorticoid deficiency, Kidney Int. 18: 58–67.PubMedCrossRefGoogle Scholar
  240. 240.
    Robertson, G. L., Aycinena, P. A., and Zerbe, R. L., 1982, Neurogenic disorders of osmoregulation, Am. J. Med. 72: 339–353.PubMedCrossRefGoogle Scholar
  241. 241.
    Bell, N. H., Schedl, H. P., and Bartter, F. C., 1964, An explanation for abnormal water retention and hypoosmolality in congestive heart failure, Am. J. Med. 36: 351–360.PubMedCrossRefGoogle Scholar
  242. 242.
    Better, O. S., Aisenbrey, G. A., Berl, T., Anderson, R. J., Handelman, W. A., Linas, S. L., Guggenheim, S. J., and Schrier, R. W., 1980, Role of antidiuretic hormone in impaired urinary dilution associated with chronic bile-duct ligation, Clin. Sci. 58: 493–500.PubMedGoogle Scholar
  243. 243.
    Linas, S. L. Anderson, R. J., Guggenheim, S. J., Robertson, G. L., and Berl, T., 1981, Role of vasopressin in impaired water excretion in conscious rats with experimental cirrhosis, Kidney Int. 20: 173–180.Google Scholar
  244. 244.
    Szatalowicz, V. L., Arnold, P. E., Chaimovitz, C., Bichet, D., Berl, T., and Schrier, R. W., 1981, Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart vailure, N. Engl. J. Med. 305: 263–266.PubMedCrossRefGoogle Scholar
  245. 245.
    Zerbe, R. L., Vinicor, F., and Robertson, G. L., 1979, Plasma vasopressin in uncontrolled diabetes mellitus, Diabetes 28: 503–508.PubMedCrossRefGoogle Scholar
  246. 246.
    Walsh, C. H., Baylis, P. H., and Malins, J. M., 1979, Plasma arginine vasopressin in diabetic ketoacidosis, Diabetologia 16: 93–96.PubMedCrossRefGoogle Scholar
  247. 247.
    Zerbe, R. L., Vinicor, F., and Robertson, G. L., 1978, Demonstration of intact osmotic regulation of vasopressin (VP) in juvenile onset diabetics (JOD), Endocrinology 102: (Suppl.): 225.Google Scholar
  248. 248.
    Zerbre, R. L., Robertson, G., Vinicor, F., and Henry, D., 1979, Orthostatic stimulation of vasopressin (VP) is exaggerated in juvenile onset diabetics (JOD), J. Am. Diabetes Assoc. 28: 349.Google Scholar
  249. 249.
    Van Houten, M., Posner, B. I., Kopriwa, B. M., and Brawer, J. R., 1979, Insulin-binding sites in the rat brain: In vivo localization to the circumventricular organs by quantitative radioautography, Endocrinology 105: 666–673.PubMedCrossRefGoogle Scholar
  250. 250.
    Möhring, J., Petri, M., Möhring, B., and Haack, D., 1976, Is vasopressin involved in the pathogenesis of malignant desoxycorticosterone hypertension in rats? Lancet 1: 170–172.PubMedCrossRefGoogle Scholar
  251. 251.
    Möhring, J., Möhring, B., Petri, M., and Haack, D., 1977, Vasopressor role of ADH in the pathogenesis of malignant DOC hypertension, Am. J. Physiol. 232: F260 — F269.PubMedGoogle Scholar
  252. 252.
    Möhring, J., Kintz, J., and Schoun, J., 1978, Role of vasopressin in blood pressure control of spontaneously hypertensive rats, Clin. Sci. Mol. Med. 55: 247s - 250s.Google Scholar
  253. 253.
    Möhring, J., Möhring, B., Petri, M., and Haack, D., 1978, Plasma vasopressin concentrations and effects of vasopressin antiserum on blood pressure in rats with malignant two-kidney Goldblatt hypertension, Circ. Res. 42: 17–22.PubMedCrossRefGoogle Scholar
  254. 254.
    Möhring, J., Kintz, J., and Schoun, J., 1979, Studies on the role of vasopressin in blood pressure control of spontaneously hypertensive rats with established hypertension (SHR, stroke-prone-strain), J. Cardiovasc. Pharmacol. 1: 593–608.PubMedCrossRefGoogle Scholar
  255. 255.
    Crofton, J. T., Share, L., Shade, R. E., Allen, C., and Tarnowski, D., 1978, Vasopressin in the rat with spontaneous hypertension, Am. J. Physiol. 235: H361 — H366.PubMedGoogle Scholar
  256. 256.
    Pullan, P.T., Johnston, C. I., Anderson, W. P., and Korner, P. I., 1980, Plasma vasopressin in blood pressure homeostasis and in experimental renal hypertension, Am. J. Physiol. 239: H81 — H87.PubMedGoogle Scholar
  257. 257.
    Manning, M., Lowbridge, J., Stier, C. T., Jr., Haldar, J., and Sawyer, W. H., 1977, [1-deaminopenicillamine, 4-valine]-8-p-arginine-vasopressin, a highly potent inhibitor of the vasopressor response to arginine vasopressin, J. Med. Chem. 20: 1228–1230.Google Scholar
  258. 258.
    Rabito, S. F., Carretero, O. A., and Scicli, A. G., 1981, Evidence against a role of vasopressin in the maintenance of high blood pressure in mineralocorticoid and renovascular hypertension, Hypertension 3: 34–38.PubMedCrossRefGoogle Scholar
  259. Padfield, P. L., Brown, J. J., Lever, A. F., and Morton, J. J., 1976, Changes of vasopressin in hypertension: Cause or effect? Lancet 1:1255–1257.Google Scholar
  260. 260.
    Shimamoto, D., Ando, T., Nakahashi, Y., Nakao, T., Tanaka, S., Sakuma, M., and Miyahara, M., 1979, Plasma and urinary ADH levels in patients with essential hypertension, Jpn. Circ. J. 43: 43–47.PubMedCrossRefGoogle Scholar
  261. 261.
    Ganguly, A., Robertson, G. L., and Weinberger, M. H., 1979, Is osmoregulation of vasopressin affected by hypertension? Clin. Res. 27: 626A.Google Scholar
  262. 262.
    Ganguly, A., and Robertson, G. L., 1980, Elevated threshold for vasopressin release in primary aldosteronism, Clin. Res. 28: 330A.Google Scholar

Copyright information

© Plenum Publishing Corporation 1985

Authors and Affiliations

  • Gary R. Robertson
    • 1
  1. 1.University of Chicago School of MedicineChicagoUSA

Personalised recommendations